{
    "2019-07-16": [
        [
            {
                "time": "2019-07-16",
                "original_text": "乐山电力上半年净利增长95%",
                "features": {
                    "keywords": [
                        "乐山电力",
                        "净利增长",
                        "95%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "电力"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-16",
                "original_text": "医药生物净减持较多，陆股通净流出",
                "features": {
                    "keywords": [
                        "医药生物",
                        "净减持",
                        "陆股通",
                        "净流出"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-16",
                "original_text": "恒瑞医药：PD-1大适应症获突破性进展，创新药梯队次第花开",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "PD-1",
                        "突破性进展",
                        "创新药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-16",
                "original_text": "注射用卡瑞利珠单抗（SHR-1210）将开展临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-16",
                "original_text": "片仔癀：上半年业绩延续快速增长势头，营销拓展持续推进",
                "features": {
                    "keywords": [
                        "片仔癀",
                        "业绩增长",
                        "营销拓展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-16",
                "original_text": "健康中国行动意见出台，三主线掘金受益股",
                "features": {
                    "keywords": [
                        "健康中国行动",
                        "政策出台",
                        "受益股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-16",
                "original_text": "货币金融行业上半年成为最大赢家",
                "features": {
                    "keywords": [
                        "货币金融",
                        "赢家"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}